A novel phase 2a study design to investigate drug-drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha-glucosidase in subjects with Pompe disease

作者:Kishnani P; Tarnopolsky M; Sivakumar K; Byrne B; Goker Alpan O; Guter K; Pervaiz M; Dasouki M; Levine T; Roberts M; Johnson F K; Valenzano K J; Lockhart D J; Boudes P
来源:17th International Congress of the World-Muscle-Society (WMS), 2012-10-09 to 2012-10-13.
DOI:10.1016/j.nmd.2012.06.165
  • 出版日期2012-10

全文